about
Human serum-derived protein removes the need for coating in defined human pluripotent stem cell culture.The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouseThe Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering ApplicationsE-cadherin acts as a regulator of transcripts associated with a wide range of cellular processes in mouse embryonic stem cellsHeparan sulfate proteoglycans and cancer.Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I.Role of heparan sulfate-2-O-sulfotransferase in the mouse.New insights into heparan sulphate biosynthesis from the study of mutant mice.Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development.Comparative quantification of the surfaceome of human multipotent mesenchymal progenitor cells.Mesenchymal stromal cells: inhibiting PDGF receptors or depleting fibronectin induces mesodermal progenitors with endothelial potential.Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking α-l-iduronidase.The heparanome--the enigma of encoding and decoding heparan sulfate sulfation.Epithelial-mesenchymal status influences how cells deposit fibrillin microfibrils.Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates.Leri's pleonosteosis, a congenital rheumatic disease, results from microduplication at 8q22.1 encompassing GDF6 and SDC2 and provides insight into systemic sclerosis pathogenesis.Glycosaminoglycans as regulators of stem cell differentiation.Three-dimensional culture of annulus fibrosus cells within PDLLA/Bioglass composite foam scaffolds: assessment of cell attachment, proliferation and extracellular matrix production.Controlling stiffness in nanostructured hydrogels produced by enzymatic dephosphorylation.Influencing hematopoietic differentiation of mouse embryonic stem cells using soluble heparin and heparan sulfate saccharides.Highly sensitive sequencing of the sulfated domains of heparan sulfate.A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase.Abrogation of E-cadherin-mediated cell-cell contact in mouse embryonic stem cells results in reversible LIF-independent self-renewal.A sugar rush for developmental biology.The biochemical determinants of tissue regeneration.Age-dependent changes in heparan sulfate in human Bruch's membrane: implications for age-related macular degeneration.Self-assembling peptide hydrogel for intervertebral disc tissue engineering.Epithelial-mesenchymal transition events during human embryonic stem cell differentiationE-cadherin and, in its absence, N-cadherin promotes Nanog expression in mouse embryonic stem cells via STAT3 phosphorylationUse of flow cytometry for characterization and fractionation of cell populations based on their expression of heparan sulfate epitopesNovel cell lines isolated from mouse embryonic stem cells exhibiting de novo methylation of the E-cadherin promoterUsing embryonic stem cells to understand how glycosaminoglycans regulate differentiationNew strategies for cartilage regeneration exploiting selected glycosaminoglycans to enhance cell fate determination
P50
Q27335859-EF45041F-8E2C-49BE-B97D-B03E2B15B7B2Q28513833-E7911813-224D-4740-AF99-25F75B0E95A2Q33851544-4F6ABB8A-FF95-4FC5-B019-7BE016DC349AQ33968068-231D9422-2940-452E-B9F1-8BBBFD0C203AQ34441253-1C9F8D34-6093-4EA4-BDDC-97B871456218Q34774580-B86D1012-8D3C-47BD-BA15-659D30A01675Q34989564-0C5B9F41-BF8D-4B94-9EBA-0F0CE833669CQ35091655-812A0A19-F9E4-4D0D-8F1A-D757EB8517BFQ35219652-EE104699-4827-4494-9C58-2C99D8783D16Q35222594-AFBF4AEA-8D44-4442-950A-9EFEF9B7F1D6Q35225801-CD78E24D-8E3D-404D-8B6E-421F81C779B6Q35423844-F9FE2545-0279-4934-ABC3-4292F46C9CD8Q36751291-1F23ED06-469B-4A56-A06E-FC5926135190Q37418467-407307B3-E034-4181-89EA-989630B83955Q38353503-E83B1360-3D21-4AD2-81F1-A7C92FCF5EECQ39268784-AB5FB801-652D-4132-836F-864B177C99CBQ39603105-4DA090DD-9A66-4B59-9CB5-BF744D14DC70Q40249065-D818EEE4-0C5A-47AB-B360-C4A50D70F299Q41620712-3BEAACA3-033D-4D47-9DDC-634D4612947CQ42691865-1C3C95B6-AD78-4725-8176-DF2D7A2FE0B2Q42814375-3E6AA77A-B904-4971-9153-6C0D551D5C4DQ44816865-3CEFECDF-B570-4625-924C-FDB3B354FF39Q45959344-DB99B80C-ECD7-4721-923E-69DC0C3AB895Q46687747-2BCFA64D-B2C8-497C-91FE-B8D3E6B79DDAQ47596802-9035D65E-F43A-490E-94AD-6CA6864947F5Q50354693-95B6708F-C819-4C85-A1C5-6A371617248EQ51128016-295D460A-B00F-4AA0-ADD3-87F2E35F927FQ80139752-42B96F8E-E556-46BB-BE1D-B3443F20966BQ84373219-8C514E0C-5B16-42A7-AFCF-4890044AF661Q85821870-DBA295B3-63F8-47A9-991D-A29FD80F7B4CQ87467780-40D7B8BF-5867-4075-A559-9FCA7BEE2493Q87922890-9B8FDE71-F204-4A61-B4CD-AB895AA41BE1Q87922905-A549EA1E-6D54-4EEA-9A1E-98EF75497C03
P50
description
researcher ORCID ID = 0000-0002-3490-2809
@en
wetenschapper
@nl
name
Catherine L Merry
@ast
Catherine L Merry
@en
Catherine L Merry
@es
Catherine L Merry
@nl
type
label
Catherine L Merry
@ast
Catherine L Merry
@en
Catherine L Merry
@es
Catherine L Merry
@nl
prefLabel
Catherine L Merry
@ast
Catherine L Merry
@en
Catherine L Merry
@es
Catherine L Merry
@nl
P106
P21
P31
P496
0000-0002-3490-2809